 | • レポートコード：GIR-2104Z00319 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、有効成分のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。有効成分の種類別市場規模（革新的医薬品有効成分、ジェネリック医薬品有効成分）、用途別市場規模（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・有効成分の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：革新的医薬品有効成分、ジェネリック医薬品有効成分 ・用途別分析2016年-2026年：腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他 ・有効成分の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・有効成分のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・有効成分のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・有効成分の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・有効成分の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Active Pharma Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Active Pharma Ingredient size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Active Pharma Ingredient market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Active Pharma Ingredient market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Market segment by Application can be divided into
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications
The key market players for global Active Pharma Ingredient market are listed below:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Active Pharma Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Pharma Ingredient Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Innovative Active Pharmaceutical Ingredients
1.2.3 Generic Active Pharmaceutical Ingredients
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Pharma Ingredient Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Central Nervous System and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other Therapeutic Applications
1.4 Global Active Pharma Ingredient Market Size & Forecast
1.4.1 Global Active Pharma Ingredient Sales in Value (2016-2026))
1.4.2 Global Active Pharma Ingredient Sales in Volume (2016-2026)
1.4.3 Global Active Pharma Ingredient Price by Type (2016-2026) & (USD/MT)
1.5 Global Active Pharma Ingredient Production Capacity Analysis
1.5.1 Global Active Pharma Ingredient Total Production Capacity (2016-2026)
1.5.2 Global Active Pharma Ingredient Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Active Pharma Ingredient Market Drivers
1.6.2 Active Pharma Ingredient Market Restraints
1.6.3 Active Pharma Ingredient Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Active Pharma Ingredient Product and Services
2.1.4 Teva Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Active Pharma Ingredient Product and Services
2.2.4 Novartis Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Active Pharma Ingredient Product and Services
2.3.4 Pfizer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Active Pharma Ingredient Product and Services
2.4.4 Johnson & Johnson Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Active Pharma Ingredient Product and Services
2.5.4 Mylan Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 North China Pharmaceutical Group
2.6.1 North China Pharmaceutical Group Details
2.6.2 North China Pharmaceutical Group Major Business
2.6.3 North China Pharmaceutical Group Active Pharma Ingredient Product and Services
2.6.4 North China Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dr. Reddy’s Laboratories
2.7.1 Dr. Reddy’s Laboratories Details
2.7.2 Dr. Reddy’s Laboratories Major Business
2.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Product and Services
2.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Active Pharma Ingredient Product and Services
2.8.4 Roche Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Aurobindo pharma
2.9.1 Aurobindo pharma Details
2.9.2 Aurobindo pharma Major Business
2.9.3 Aurobindo pharma Active Pharma Ingredient Product and Services
2.9.4 Aurobindo pharma Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Sun Pharmaceutical Industries
2.10.1 Sun Pharmaceutical Industries Details
2.10.2 Sun Pharmaceutical Industries Major Business
2.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Product and Services
2.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Boehringer Ingelheim GmbH
2.11.1 Boehringer Ingelheim GmbH Details
2.11.2 Boehringer Ingelheim GmbH Major Business
2.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Product and Services
2.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business
2.12.3 Bayer Active Pharma Ingredient Product and Services
2.12.4 Bayer Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 BASF
2.13.1 BASF Details
2.13.2 BASF Major Business
2.13.3 BASF Active Pharma Ingredient Product and Services
2.13.4 BASF Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 DSM
2.14.1 DSM Details
2.14.2 DSM Major Business
2.14.3 DSM Active Pharma Ingredient Product and Services
2.14.4 DSM Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Zhejiang Medicine
2.15.1 Zhejiang Medicine Details
2.15.2 Zhejiang Medicine Major Business
2.15.3 Zhejiang Medicine Active Pharma Ingredient Product and Services
2.15.4 Zhejiang Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Biocon
2.16.1 Biocon Details
2.16.2 Biocon Major Business
2.16.3 Biocon Active Pharma Ingredient Product and Services
2.16.4 Biocon Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Johnson Matthey
2.17.1 Johnson Matthey Details
2.17.2 Johnson Matthey Major Business
2.17.3 Johnson Matthey Active Pharma Ingredient Product and Services
2.17.4 Johnson Matthey Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Hisun Pharmacy
2.18.1 Hisun Pharmacy Details
2.18.2 Hisun Pharmacy Major Business
2.18.3 Hisun Pharmacy Active Pharma Ingredient Product and Services
2.18.4 Hisun Pharmacy Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Cambrex
2.19.1 Cambrex Details
2.19.2 Cambrex Major Business
2.19.3 Cambrex Active Pharma Ingredient Product and Services
2.19.4 Cambrex Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Shandong Xinhua Pharmaceutical
2.20.1 Shandong Xinhua Pharmaceutical Details
2.20.2 Shandong Xinhua Pharmaceutical Major Business
2.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product and Services
2.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Lonza group
2.21.1 Lonza group Details
2.21.2 Lonza group Major Business
2.21.3 Lonza group Active Pharma Ingredient Product and Services
2.21.4 Lonza group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Huahai Pharmaceutical
2.22.1 Huahai Pharmaceutical Details
2.22.2 Huahai Pharmaceutical Major Business
2.22.3 Huahai Pharmaceutical Active Pharma Ingredient Product and Services
2.22.4 Huahai Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Haerbin Pharmaceutical Group
2.23.1 Haerbin Pharmaceutical Group Details
2.23.2 Haerbin Pharmaceutical Group Major Business
2.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Product and Services
2.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.24 Cipla
2.24.1 Cipla Details
2.24.2 Cipla Major Business
2.24.3 Cipla Active Pharma Ingredient Product and Services
2.24.4 Cipla Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.25 Tian Yao
2.25.1 Tian Yao Details
2.25.2 Tian Yao Major Business
2.25.3 Tian Yao Active Pharma Ingredient Product and Services
2.25.4 Tian Yao Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.26 Lupin
2.26.1 Lupin Details
2.26.2 Lupin Major Business
2.26.3 Lupin Active Pharma Ingredient Product and Services
2.26.4 Lupin Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.27 North East Pharmaceutical
2.27.1 North East Pharmaceutical Details
2.27.2 North East Pharmaceutical Major Business
2.27.3 North East Pharmaceutical Active Pharma Ingredient Product and Services
2.27.4 North East Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.28 Albemarle
2.28.1 Albemarle Details
2.28.2 Albemarle Major Business
2.28.3 Albemarle Active Pharma Ingredient Product and Services
2.28.4 Albemarle Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.29 Shandong Lukang Pharmaceutical
2.29.1 Shandong Lukang Pharmaceutical Details
2.29.2 Shandong Lukang Pharmaceutical Major Business
2.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Product and Services
2.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.30 Jiangsu Hengrui Medicine
2.30.1 Jiangsu Hengrui Medicine Details
2.30.2 Jiangsu Hengrui Medicine Major Business
2.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Product and Services
2.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Active Pharma Ingredient Sales by Manufacturer
3.1 Global Active Pharma Ingredient Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Active Pharma Ingredient Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Active Pharma Ingredient
3.4 Market Concentration Rate
3.4.1 Top 3 Active Pharma Ingredient Manufacturer Market Share
3.4.2 Top 6 Active Pharma Ingredient Manufacturer Market Share
3.5 Global Active Pharma Ingredient Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Active Pharma Ingredient Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Active Pharma Ingredient Market Size by Region
4.1.1 Global Active Pharma Ingredient Sales in Volume by Region (2016-2026)
4.1.2 Global Active Pharma Ingredient Revenue by Region (2016-2026)
4.2 North America Active Pharma Ingredient Revenue (2016-2026)
4.3 Europe Active Pharma Ingredient Revenue (2016-2026)
4.4 Asia-Pacific Active Pharma Ingredient Revenue (2016-2026)
4.5 South America Active Pharma Ingredient Revenue (2016-2026)
4.6 Middle East and Africa Active Pharma Ingredient Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Active Pharma Ingredient Sales in Volume by Type (2016-2026)
5.2 Global Active Pharma Ingredient Revenue by Type (2016-2026)
5.3 Global Active Pharma Ingredient Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Active Pharma Ingredient Sales in Volume by Application (2016-2026)
6.2 Global Active Pharma Ingredient Revenue by Application (2016-2026)
6.3 Global Active Pharma Ingredient Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Active Pharma Ingredient Sales by Type (2016-2026)
7.2 North America Active Pharma Ingredient Sales by Application (2016-2026)
7.3 North America Active Pharma Ingredient Market Size by Country
7.3.1 North America Active Pharma Ingredient Sales in Volume by Country (2016-2026)
7.3.2 North America Active Pharma Ingredient Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Active Pharma Ingredient Sales by Type (2016-2026)
8.2 Europe Active Pharma Ingredient Sales by Application (2016-2026)
8.3 Europe Active Pharma Ingredient Market Size by Country
8.3.1 Europe Active Pharma Ingredient Sales in Volume by Country (2016-2026)
8.3.2 Europe Active Pharma Ingredient Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Active Pharma Ingredient Sales by Type (2016-2026)
9.2 Asia-Pacific Active Pharma Ingredient Sales by Application (2016-2026)
9.3 Asia-Pacific Active Pharma Ingredient Market Size by Region
9.3.1 Asia-Pacific Active Pharma Ingredient Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Active Pharma Ingredient Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Active Pharma Ingredient Sales by Type (2016-2026)
10.2 South America Active Pharma Ingredient Sales by Application (2016-2026)
10.3 South America Active Pharma Ingredient Market Size by Country
10.3.1 South America Active Pharma Ingredient Sales in Volume by Country (2016-2026)
10.3.2 South America Active Pharma Ingredient Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Active Pharma Ingredient Sales by Type (2016-2026)
11.2 Middle East & Africa Active Pharma Ingredient Sales by Application (2016-2026)
11.3 Middle East & Africa Active Pharma Ingredient Market Size by Country
11.3.1 Middle East & Africa Active Pharma Ingredient Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Active Pharma Ingredient Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Active Pharma Ingredient Typical Distributors
12.3 Active Pharma Ingredient Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Active Pharma Ingredient Revenue by Type, (USD Million), 2021-2026
Table 2. Global Active Pharma Ingredient Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Active Pharma Ingredient Product and Services
Table 6. Teva Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Active Pharma Ingredient Product and Services
Table 10. Novartis Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Active Pharma Ingredient Product and Services
Table 14. Pfizer Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Active Pharma Ingredient Product and Services
Table 18. Johnson & Johnson Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Active Pharma Ingredient Product and Services
Table 22. Mylan Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. North China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 24. North China Pharmaceutical Group Major Business
Table 25. North China Pharmaceutical Group Active Pharma Ingredient Product and Services
Table 26. North China Pharmaceutical Group Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Dr. Reddy’s Laboratories Major Business
Table 29. Dr. Reddy’s Laboratories Active Pharma Ingredient Product and Services
Table 30. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Major Business
Table 33. Roche Active Pharma Ingredient Product and Services
Table 34. Roche Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Aurobindo pharma Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo pharma Major Business
Table 37. Aurobindo pharma Active Pharma Ingredient Product and Services
Table 38. Aurobindo pharma Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Sun Pharmaceutical Industries Major Business
Table 41. Sun Pharmaceutical Industries Active Pharma Ingredient Product and Services
Table 42. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim GmbH Major Business
Table 45. Boehringer Ingelheim GmbH Active Pharma Ingredient Product and Services
Table 46. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Bayer Basic Information, Manufacturing Base and Competitors
Table 48. Bayer Major Business
Table 49. Bayer Active Pharma Ingredient Product and Services
Table 50. Bayer Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. BASF Basic Information, Manufacturing Base and Competitors
Table 52. BASF Major Business
Table 53. BASF Active Pharma Ingredient Product and Services
Table 54. BASF Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. DSM Basic Information, Manufacturing Base and Competitors
Table 56. DSM Major Business
Table 57. DSM Active Pharma Ingredient Product and Services
Table 58. DSM Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 60. Zhejiang Medicine Major Business
Table 61. Zhejiang Medicine Active Pharma Ingredient Product and Services
Table 62. Zhejiang Medicine Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Biocon Basic Information, Manufacturing Base and Competitors
Table 64. Biocon Major Business
Table 65. Biocon Active Pharma Ingredient Product and Services
Table 66. Biocon Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Johnson Matthey Basic Information, Manufacturing Base and Competitors
Table 68. Johnson Matthey Major Business
Table 69. Johnson Matthey Active Pharma Ingredient Product and Services
Table 70. Johnson Matthey Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 72. Hisun Pharmacy Major Business
Table 73. Hisun Pharmacy Active Pharma Ingredient Product and Services
Table 74. Hisun Pharmacy Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Cambrex Basic Information, Manufacturing Base and Competitors
Table 76. Cambrex Major Business
Table 77. Cambrex Active Pharma Ingredient Product and Services
Table 78. Cambrex Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Shandong Xinhua Pharmaceutical Major Business
Table 81. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product and Services
Table 82. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Lonza group Basic Information, Manufacturing Base and Competitors
Table 84. Lonza group Major Business
Table 85. Lonza group Active Pharma Ingredient Product and Services
Table 86. Lonza group Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Huahai Pharmaceutical Major Business
Table 89. Huahai Pharmaceutical Active Pharma Ingredient Product and Services
Table 90. Huahai Pharmaceutical Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Haerbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 92. Haerbin Pharmaceutical Group Major Business
Table 93. Haerbin Pharmaceutical Group Active Pharma Ingredient Product and Services
Table 94. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Cipla Basic Information, Manufacturing Base and Competitors
Table 96. Cipla Major Business
Table 97. Cipla Active Pharma Ingredient Product and Services
Table 98. Cipla Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Tian Yao Basic Information, Manufacturing Base and Competitors
Table 100. Tian Yao Major Business
Table 101. Tian Yao Active Pharma Ingredient Product and Services
Table 102. Tian Yao Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Lupin Basic Information, Manufacturing Base and Competitors
Table 104. Lupin Major Business
Table 105. Lupin Active Pharma Ingredient Product and Services
Table 106. Lupin Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. North East Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 108. North East Pharmaceutical Major Business
Table 109. North East Pharmaceutical Active Pharma Ingredient Product and Services
Table 110. North East Pharmaceutical Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Albemarle Basic Information, Manufacturing Base and Competitors
Table 112. Albemarle Major Business
Table 113. Albemarle Active Pharma Ingredient Product and Services
Table 114. Albemarle Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 115. Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Shandong Lukang PharmaceuticalMajor Business
Table 117. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product and Services
Table 118. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 119. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 120. Jiangsu Hengrui Medicine Major Business
Table 121. Jiangsu Hengrui Medicine Active Pharma Ingredient Product and Services
Table 122. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 123. Global Active Pharma Ingredient Sales by Manufacturer (2019-2021e) & (MT)
Table 124. Global Active Pharma Ingredient Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 125. Market Position of Manufacturers in Active Pharma Ingredient, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 126. Global Active Pharma Ingredient Production Capacity by Company, (MT): 2020 VS 2021
Table 127. Head Office and Active Pharma Ingredient Production Site of Key Manufacturer
Table 128. Global Active Pharma Ingredient Sales by Region (2016-2021e) & (MT)
Table 129. Global Active Pharma Ingredient Sales by Region (2021-2026) & (MT)
Table 130. Global Active Pharma Ingredient Revenue by Region (2016-2021e) & (USD Million)
Table 131. Global Active Pharma Ingredient Revenue by Region (2021-2026) & (USD Million)
Table 132. Global Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 133. Global Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 134. Global Active Pharma Ingredient Revenue by Type (2016-2021e) & (USD Million)
Table 135. Global Active Pharma Ingredient Revenue by Type (2021-2026) & (USD Million)
Table 136. Global Active Pharma Ingredient Price by Type (2016-2021e) & (USD/MT)
Table 137. Global Active Pharma Ingredient Price by Type (2021-2026) & (USD/MT)
Table 138. Global Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 139. Global Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 140. Global Active Pharma Ingredient Revenue by Application (2016-2021e) & (USD Million)
Table 141. Global Active Pharma Ingredient Revenue by Application (2021-2026) & (USD Million)
Table 142. Global Active Pharma Ingredient Price by Application (2016-2021e) & (USD/MT)
Table 143. Global Active Pharma Ingredient Price by Application (2021-2026) & (USD/MT)
Table 144. North America Active Pharma Ingredient Sales by Country (2016-2021e) & (MT)
Table 145. North America Active Pharma Ingredient Sales by Country (2021-2026) & (MT)
Table 146. North America Active Pharma Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 147. North America Active Pharma Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 148. North America Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 149. North America Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 150. North America Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 151. North America Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 152. Europe Active Pharma Ingredient Sales by Country (2016-2021e) & (MT)
Table 153. Europe Active Pharma Ingredient Sales by Country (2021-2026) & (MT)
Table 154. Europe Active Pharma Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 155. Europe Active Pharma Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 156. Europe Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 157. Europe Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 158. Europe Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 159. Europe Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 160. Asia-Pacific Active Pharma Ingredient Sales by Region (2016-2021e) & (MT)
Table 161. Asia-Pacific Active Pharma Ingredient Sales by Region (2021-2026) & (MT)
Table 162. Asia-Pacific Active Pharma Ingredient Revenue by Region (2016-2021e) & (USD Million)
Table 163. Asia-Pacific Active Pharma Ingredient Revenue by Region (2021-2026) & (USD Million)
Table 164. Asia-Pacific Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 165. Asia-Pacific Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 166. Asia-Pacific Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 167. Asia-Pacific Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 168. South America Active Pharma Ingredient Sales by Country (2016-2021e) & (MT)
Table 169. South America Active Pharma Ingredient Sales by Country (2021-2026) & (MT)
Table 170. South America Active Pharma Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 171. South America Active Pharma Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 172. South America Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 173. South America Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 174. South America Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 175. South America Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 176. Middle East & Africa Active Pharma Ingredient Sales by Country (2016-2021e) & (MT)
Table 177. Middle East & Africa Active Pharma Ingredient Sales by Country (2021-2026) & (MT)
Table 178. Middle East & Africa Active Pharma Ingredient Revenue by Country (2016-2021e) & (USD Million)
Table 179. Middle East & Africa Active Pharma Ingredient Revenue by Country (2021-2026) & (USD Million)
Table 180. Middle East & Africa Active Pharma Ingredient Sales by Type (2016-2021e) & (MT)
Table 181. Middle East & Africa Active Pharma Ingredient Sales by Type (2021-2026) & (MT)
Table 182. Middle East & Africa Active Pharma Ingredient Sales by Application (2016-2021e) & (MT)
Table 183. Middle East & Africa Active Pharma Ingredient Sales by Application (2021-2026) & (MT)
Table 184. Direct Channel Pros & Cons
Table 185. Indirect Channel Pros & Cons
Table 186. Active Pharma Ingredient Typical Distributors
Table 187. Active Pharma Ingredient Typical Customers
List of Figures
Figure 1. Active Pharma Ingredient Picture
Figure 2. Global Active Pharma Ingredient Sales Market Share by Type in 2020
Figure 3. Innovative Active Pharmaceutical Ingredients
Figure 4. Generic Active Pharmaceutical Ingredients
Figure 5. Global Active Pharma Ingredient Sales Market Share by Application in 2020
Figure 6. Oncology
Figure 7. Cardiovascular Disease
Figure 8. Diabetes
Figure 9. Central Nervous System and Neurological Disorders
Figure 10. Endocrinology
Figure 11. Other Therapeutic Applications
Figure 12. Global Active Pharma Ingredient Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 13. Global Active Pharma Ingredient Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Active Pharma Ingredient Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Active Pharma Ingredient Sales (2016-2026) & (MT)
Figure 34. Global Active Pharma Ingredient Production Capacity (2016-2026) & (MT)
Figure 35. Global Active Pharma Ingredient Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Active Pharma Ingredient Market Drivers
Figure 37. Active Pharma Ingredient Market Restraints
Figure 38. Active Pharma Ingredient Market Trends
Figure 39. Global Active Pharma Ingredient Sales Market Share by Manufacturer in 2020
Figure 40. Global Active Pharma Ingredient Revenue Market Share by Manufacturer in 2020
Figure 41. Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Active Pharma Ingredient Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Active Pharma Ingredient Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Active Pharma Ingredient Sales Market Share by Region (2016-2026)
Figure 45. Global Active Pharma Ingredient Revenue Market Share by Region (2016-2026)
Figure 46. North America Active Pharma Ingredient Revenue (2016-2026) & (USD Million)
Figure 47. Europe Active Pharma Ingredient Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Active Pharma Ingredient Revenue (2016-2026) & (USD Million)
Figure 49. South America Active Pharma Ingredient Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Active Pharma Ingredient Revenue (2016-2026) & (USD Million)
Figure 51. Global Active Pharma Ingredient Sales Market Share by Type (2016-2026)
Figure 52. Global Active Pharma Ingredient Revenue Market Share by Type (2016-2026)
Figure 53. Global Active Pharma Ingredient Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 55. Global Active Pharma Ingredient Revenue Market Share by Application (2016-2026)
Figure 56. Global Active Pharma Ingredient Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Active Pharma Ingredient Sales Market Share by Country (2016-2026)
Figure 58. North America Active Pharma Ingredient Revenue Market Share by Country (2016-2026)
Figure 59. North America Active Pharma Ingredient Sales Market Share by Type (2016-2026)
Figure 60. North America Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 61. Europe Active Pharma Ingredient Sales Market Share by Country (2016-2026)
Figure 62. Europe Active Pharma Ingredient Revenue Market Share by Country (2016-2026)
Figure 63. Europe Active Pharma Ingredient Sales Market Share by Type (2016-2026)
Figure 64. Europe Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Active Pharma Ingredient Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Active Pharma Ingredient Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Active Pharma Ingredient Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 69. South America Active Pharma Ingredient Sales Market Share by Country (2016-2026)
Figure 70. South America Active Pharma Ingredient Revenue Market Share by Country (2016-2026)
Figure 71. South America Active Pharma Ingredient Sales Market Share by Type (2016-2026)
Figure 72. South America Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Active Pharma Ingredient Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Active Pharma Ingredient Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Active Pharma Ingredient Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Active Pharma Ingredient Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のヘパリン有効成分市場 2021：企業別、地域別、種類・用途別 The Heparin Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界の木材防腐剤・コーティング剤有効成分市場 2021：企業別、地域別、種類・用途別 The Wood Preservative Chemicals and Coatings Active Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 世界のアンチエイジング有効成分市場 2021：企業別、地域別、種類・用途別 The Anti Ageing Active Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の化粧品有効成分市場 2021：企業別、地域別、種類・用途別 The Cosmetic Active Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の新有効成分食品カプセル化市場規模・現状・予測（2021年-2027年） Organic structures consumed in food are packaged in units that carry the active ingredients and protect the encapsulated active substances until they are shipped to the food. In the future, nutritional supplements and functional foods may be tailored to individual metabolic needs and related to the …